IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v427y2004i6974d10.1038_nature02214.html
   My bibliography  Save this article

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Author

Listed:
  • Simone Rost

    (University of Würzburg, Biozentrum
    Institute of Human Genetics, GSF National Research Center)

  • Andreas Fregin

    (University of Würzburg, Biozentrum)

  • Vytautas Ivaskevicius

    (Johann Wolfgang Goethe-Universität)

  • Ernst Conzelmann

    (University of Würzburg, Biozentrum)

  • Konstanze Hörtnagel

    (Institute of Human Genetics, GSF National Research Center)

  • Hans-Joachim Pelz

    (Institute for Nematology and Vertebrate Research)

  • Knut Lappegard

    (Nordland Hospital)

  • Erhard Seifried

    (Johann Wolfgang Goethe-Universität)

  • Inge Scharrer

    (Johann Wolfgang Goethe-Universität)

  • Edward G. D. Tuddenham

    (Imperial College)

  • Clemens R. Müller

    (University of Würzburg, Biozentrum)

  • Tim M. Strom

    (Institute of Human Genetics, GSF National Research Center
    Technical University)

  • Johannes Oldenburg

    (University of Würzburg, Biozentrum
    Johann Wolfgang Goethe-Universität)

Abstract

Coumarin derivatives such as warfarin represent the therapy of choice for the long-term treatment and prevention of thromboembolic events. Coumarins target blood coagulation by inhibiting the vitamin K epoxide reductase multiprotein complex (VKOR)1. This complex recycles vitamin K 2,3-epoxide to vitamin K hydroquinone, a cofactor that is essential for the post-translational γ-carboxylation of several blood coagulation factors2,3. Despite extensive efforts, the components of the VKOR complex have not been identified4,5,6,7,8. The complex has been proposed to be involved in two heritable human diseases: combined deficiency of vitamin-K-dependent clotting factors type 2 (VKCFD2; Online Mendelian Inheritance in Man (OMIM) 607473), and resistance to coumarin-type anticoagulant drugs (warfarin resistance, WR; OMIM 122700). Here we identify, by using linkage information from three species, the gene vitamin K epoxide reductase complex subunit 1 (VKORC1), which encodes a small transmembrane protein of the endoplasmic reticulum. VKORC1 contains missense mutations in both human disorders and in a warfarin-resistant rat strain. Overexpression of wild-type VKORC1, but not VKORC1 carrying the VKCFD2 mutation, leads to a marked increase in VKOR activity, which is sensitive to warfarin inhibition.

Suggested Citation

  • Simone Rost & Andreas Fregin & Vytautas Ivaskevicius & Ernst Conzelmann & Konstanze Hörtnagel & Hans-Joachim Pelz & Knut Lappegard & Erhard Seifried & Inge Scharrer & Edward G. D. Tuddenham & Clemens , 2004. "Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2," Nature, Nature, vol. 427(6974), pages 537-541, February.
    • Handle: RePEc:nat:nature:v:427:y:2004:i:6974:d:10.1038_nature02214
    DOI: 10.1038/nature02214
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature02214
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature02214?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zhiyuan Ma & Ping Wang & Zehui Gao & Ruobing Wang & Koroush Khalighi, 2018. "Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-12, October.
    2. Da-Yun Jin & Xuejie Chen & Yizhou Liu & Craig M. Williams & Lars C. Pedersen & Darrel W. Stafford & Jian-Ke Tie, 2023. "A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase," Nature Communications, Nature, vol. 14(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:427:y:2004:i:6974:d:10.1038_nature02214. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.